Western blotting in the diagnosis of duodenal-biliary and pancreaticobiliary refluxes in biliary diseases.
BACKGROUND
Currently adopted diagnostic methods for duodenal-biliary and pancreaticobiliary refluxes carry many flaws, so the incidence of the two refluxes demands further larger sample size studies. This study aimed to evaluate Western blotting for the diagnosis of refluxes in biliary diseases.


METHODS
An oral radionuclide 99mTc-DTPA test (radionuclide, RN) was conducted for the observation of duodenal-biliary reflux prior to measuring bile radioactivity and Western blotting for detecting bile enterokinase (EK). Pancreaticobiliary reflux was assessed by biochemical and Western blotting tests for biliary amylase activity and trypsin-1, respectively. In accordance with bile sample origin, our samples were classified into ductal bile and gall bile groups; based on each individual biliary disease, we further classified the ductal bile group into five sub-groups, and the gall bile group into four sub-groups. Western blotting was conducted to assess the two refluxes in biliary diseases.


RESULTS
Consistencies were noted between EK and RN tests when diagnosing duodenal-biliary reflux (P<0.001). The amylase and trypsin-1 tests also showed consistency in diagnosing pancreaticobiliary reflux (P<0.001). Amylase and lipase levels within gall and ductal bile were strongly correlated (P<0.05). In the common bile duct pigment stone group, the EK and trypsin-1 positive rates were found to be insignificant (P>0.05); in the common bile duct cyst group, the EK positive rate was significantly lower than the trypsin-1 positive rate (P<0.05).


CONCLUSIONS
Western blotting can accurately reflect duodenal-biliary and pancreaticobiliary refluxes. EK has greater sensitivity than RN for duodenal-biliary reflux. The majority of biliary amylase and lipase comes from the pancreas in all biliary diseases; pancreaticobiliary reflux is the predominant source in the common bile duct cyst group and duodenal-biliary reflux is responsible for the ductal pigment stone group.
Xian
Guo-Zhe
GZ
Department of General Surgery, Shengjing Hospital, China Medical University, Shenyang 110004, China.
Wu
Shuo-Dong
SD
Chen
Chun-Chih
CC
Su
Yang
Y
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000681:Amylases / Q000032:analysis; D001646:Bile / Q000000981:diagnostic imaging / Q000201:enzymology*; D001655:Bile Reflux / Q000175:diagnosis* / Q000000981:diagnostic imaging; D001660:Biliary Tract Diseases / Q000175:diagnosis* / Q000000981:diagnostic imaging; D015153:Blotting, Western; D002648:Child; D002675:Child, Preschool; D004796:Clinical Enzyme Tests; D004765:Enteropeptidase / Q000032:analysis; D005260:Female; D006801:Humans; D006867:Hydrolases / Q000032:analysis*; D007223:Infant; D008049:Lipase / Q000032:analysis; D008297:Male; D008875:Middle Aged; D010182:Pancreatic Diseases / Q000175:diagnosis* / Q000000981:diagnostic imaging; D011237:Predictive Value of Tests; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000008:administration & dosage; D016284:Technetium Tc 99m Pentetate / Q000008:administration & dosage; D014357:Trypsin / Q000032:analysis; D055815:Young Adult
D019275:Radiopharmaceuticals; D006867:Hydrolases; D008049:Lipase; D000681:Amylases; C489303:PRSS1 protein, human; D014357:Trypsin; D004765:Enteropeptidase; D016284:Technetium Tc 99m Pentetate